GSK plc - 10%+ Owner at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by GSK plc since 11/5/2023

Holdings reported by GSK plc for Lyell Immunopharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 30.3M $69M $2.28 Jun 21, 2021 Indirect
Series AA Preferred Stock 0 Jun 21, 2021 Indirect Common Stock

Transactions reported by GSK plc for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.